IFI207 promotes antiviral responses by modulating STING ubiquitination and degradation

This study demonstrates that the murine protein IFI207 enhances antiviral immunity by inhibiting K63-linked ubiquitination and subsequent lysosomal degradation of STING, thereby amplifying type I interferon responses and controlling viral infections such as Murine Leukemia Virus and Herpes Simplex Virus 1.

The Gist

The Big Picture: The Body's "Security System" Upgrade

Imagine your body is a high-tech fortress. Inside, there is a master alarm system called STING. When a virus (like a burglar) breaks in, STING sounds the alarm, calling the immune system's "police" (interferons) to fight the infection.

However, like any alarm system, STING has a safety switch. Once the alarm has been ringing for a while, the system automatically shuts it off to prevent the whole fortress from going crazy. This is done by tagging the alarm with a "trash can" sticker (a process called K63 ubiquitination) and sending it to the garbage disposal (the lysosome) to be destroyed.

The Problem: Sometimes, the virus is so sneaky that it tricks the body into shutting off the alarm too quickly, allowing the infection to win.

The Hero: This paper introduces a new character named IFI207. Think of IFI207 as a bodyguard or a security guard that stands next to the STING alarm. Its job is to stop the "trash can sticker" from being put on the alarm, keeping the alarm ringing longer and louder so the body can win the fight against the virus.

---

How It Works: The Story in Three Acts

Act 1: The "Trash Can" Sticker (Ubiquitination)

Normally, when STING detects a virus, it gets activated. But to stop the alarm from ringing forever, the cell attaches a specific tag (K63 ubiquitin) to STING.

• The Analogy: Imagine STING is a fire alarm. Once it's been pulled, a janitor comes and puts a "Do Not Use" sticker on it and throws it in the trash. This is necessary to reset the system, but if it happens too fast, the fire (virus) keeps burning.
• The Discovery: The researchers found that in mice without IFI207, the janitor throws the alarm away very quickly. The alarm stops ringing, and the virus wins.

Act 2: The Bodyguard Intervenes

The paper shows that IFI207 binds directly to STING.

• The Analogy: IFI207 is like a bodyguard who grabs the fire alarm and says, "No, you can't throw this away yet! We still have a fire!"
• The Mechanism: IFI207 physically blocks the "trash can sticker" (K63 ubiquitin) from being attached to STING. Because the sticker isn't there, the cell's garbage disposal system (specifically a machine called HRS and the ESCRT complex) doesn't recognize STING as trash.
• The Result: STING stays active in the cell longer. It keeps shouting "Intruder!" to the immune system, producing more interferons to fight the virus.

Act 3: Winning the Battle (In Mice)

The researchers tested this in mice using two different types of "burglars":

1. Herpes Simplex Virus (HSV-1): A DNA virus. Mice without IFI207 got much sicker and had more virus in their brains than mice with IFI207.
2. Murine Leukemia Virus (MLV): A retrovirus. Mice missing IFI207 (especially in their dendritic cells, which are the "scouts" of the immune system) couldn't stop the virus from spreading.

The Conclusion: IFI207 is a crucial upgrade to the mouse immune system. It evolved specifically to keep the STING alarm ringing long enough to defeat these specific viruses.

---

Why Does This Matter?

1. Evolutionary Arms Race: The paper suggests that mice have evolved this special "bodyguard" (IFI207) because they have been fighting viruses for millions of years. The virus tries to shut down the alarm; the mouse evolves a bodyguard to stop the shutdown.
2. Human Health: While humans don't have IFI207 (it's unique to mice), we have similar proteins (like IFI16). Understanding how IFI207 works helps scientists understand how to keep our own immune alarms active when we need them to be.
3. Future Treatments: If we can figure out how to mimic IFI207's effect in humans, we might be able to create drugs that boost our immune response against stubborn viruses or even cancer, by preventing our immune system from "giving up" too early.

Summary in One Sentence

IFI207 is a molecular bodyguard that protects the immune system's alarm (STING) from being thrown in the trash too soon, ensuring the body fights off viral infections more effectively.

Technical Summary

1. Problem Statement

The innate immune system relies on the STING (Stimulator of Interferon Genes) pathway to detect cytosolic DNA and initiate Type I Interferon (IFN-I) responses against viral infections. While STING activation is well-characterized, its regulation via post-translational modifications—specifically ubiquitination—is complex.

• The Conflict: STING activation requires K63-linked ubiquitination to recruit TBK1 and initiate signaling. However, this same K63-linked ubiquitination serves as a signal for the ESCRT (Endosomal Sorting Complex Required for Transport) machinery (specifically the protein HRS) to target STING for lysosomal degradation, thereby terminating the signal.
• The Gap: The mouse genome contains an expanded locus of AIM2-like receptors (ALRs), including IFI207, which shows signs of strong positive selection (suggesting pathogen-driven evolution). Previous work established that IFI207 stabilizes STING and enhances antiviral responses, but the molecular mechanism by which IFI207 prevents STING degradation remained unknown.

2. Methodology

The authors employed a combination of genetic, molecular, and virological approaches using Mus species (mice):

• Genetic Models: Utilized IFI207 Knockout (KO) mice, STING mutant (STINGmut) mice, and mice with conditional deletions of DDX41 (a retroviral sensor) in specific cell types (Dendritic Cells via CD11c-Cre and Macrophages via LysM-Cre).
• Cell Models: Primary Bone Marrow-Derived Macrophages (BMDMs), Bone Marrow-Derived Dendritic Cells (BMDCs), and fibroblasts from WT and KO mice; HEK293T cells for transfection studies.
• Pharmacological Inhibition: Used TAK243 (an E1 ubiquitin-activating enzyme inhibitor) to block global ubiquitination and Bafilomycin A1 (BafA1) to inhibit lysosomal acidification and degradation.
• Stimulation & Infection:
  • Chemical stimulation with DMXAA (a STING agonist).
  • Viral infection with Herpes Simplex Virus 1 (HSV-1) and Murine Leukemia Virus (MLV).
• Assays:
  • Western Blotting: To quantify total STING, phosphorylated STING (p-STING), p-TBK1, p-IRF3, and ubiquitination status.
  • Immunoprecipitation (IP): To assess interactions between STING, HRS, and IFI207, and to detect K63-linked ubiquitination.
  • AlphaFold Modeling: To predict the structural interaction between IFI207 and STING dimers.
  • In Vivo Studies: Intranasal HSV-1 infection and intraperitoneal MLV infection in newborn mice to measure viral loads and weight loss.

3. Key Contributions & Results

A. IFI207 Stabilizes STING by Inhibiting K63-Linked Ubiquitination

• Observation: Basal STING protein levels were significantly reduced (20–30%) in IFI207 KO cells compared to WT, despite equivalent mRNA levels.
• Mechanism: Treatment with TAK243 (blocking ubiquitination) restored STING levels in KO cells, whereas BafA1 (blocking lysosomal degradation) had a partial effect. This indicated that IFI207 prevents STING degradation by inhibiting the ubiquitination step required for lysosomal targeting.
• Specificity: Immunoprecipitation assays using K63-specific antibodies revealed that IFI207 significantly reduces K63-linked polyubiquitination of activated STING. In IFI207 KO cells, activated STING is hyper-ubiquitinated at K63 residues.

B. Disruption of the STING-HRS Interaction

• HRS Binding: HRS (a component of ESCRT-0) recognizes K63-ubiquitinated proteins to target them for lysosomal degradation.
• Finding: In the presence of IFI207, the interaction between activated STING and HRS is significantly reduced. In IFI207 KO cells, HRS binds more robustly to STING, leading to accelerated degradation.
• Complex Formation: IFI207 co-immunoprecipitates with HRS only in the presence of STING, suggesting it acts as a shield within the STING complex rather than binding HRS directly.
• Structural Insight: AlphaFold modeling suggests IFI207 binds STING via its unique N-terminal S/T-rich coiled domain and the C-terminal HIN domain, potentially sterically hindering the ubiquitination sites or the HRS binding interface.

C. Enhanced Antiviral Signaling

• Signaling Cascade: By preventing STING degradation, IFI207 prolongs the presence of active STING, leading to increased phosphorylation of TBK1 and IRF3, and subsequent higher production of IFN-β and pro-inflammatory cytokines.
• Viral Response:
  • HSV-1: IFI207 KO cells and mice showed reduced IFN-β production and higher viral loads (measured by HSV DNA in olfactory bulbs) compared to WT.
  • MLV: IFI207 KO mice exhibited higher retroviral titers.

D. Cell-Type Specificity and Evolutionary Context

• Dendritic Cells (DCs): Using conditional KO mice, the authors demonstrated that the loss of IFI207 specifically in Dendritic Cells (but not macrophages) combined with DDX41 loss resulted in the highest susceptibility to MLV. This identifies DCs as the critical site for IFI207-mediated STING stabilization during retroviral infection.
• Evolutionary Pressure: The expansion of the Alr locus in mice, including the unique IFI207 gene, is likely driven by endemic viral pressures (e.g., murine retroviruses and herpesviruses).

4. Significance

• Novel Regulatory Mechanism: The study identifies a distinct mechanism where an ALR (IFI207) does not act as a primary sensor but as a modulator that fine-tunes the STING pathway. It shifts the balance from "signal termination" (degradation) to "signal amplification" (stabilization).
• Therapeutic Implications: Understanding how host proteins regulate STING turnover is crucial for developing therapies. Enhancing IFI207-like mechanisms could boost antiviral immunity, while inhibiting them might help control STING-driven autoinflammatory diseases.
• Evolutionary Insight: The research provides evidence that the rapid expansion of the mouse Alr gene family is an evolutionary adaptation to specific viral pathogens, highlighting the arms race between host immunity and viral evasion.
• Resolution of Paradox: It resolves the paradox of how K63 ubiquitination can be both necessary for activation (TBK1 recruitment) and a signal for degradation, showing that IFI207 specifically limits the degradative K63 ubiquitination to sustain the antiviral response.

Conclusion

Enya et al. demonstrate that IFI207 acts as a critical stabilizer of the STING pathway in mice. By binding to activated STING and blocking K63-linked ubiquitination, IFI207 prevents the recruitment of HRS and subsequent lysosomal degradation. This mechanism ensures sustained Type I interferon responses, significantly enhancing host defense against DNA viruses (HSV-1) and retroviruses (MLV), particularly in dendritic cells.